Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/1996
03/26/1996US5502079 N-phenylalkyl substituted α-amino carboxamide derivatives and process for their preparation
03/26/1996US5502077 Fatty acid composition
03/26/1996US5502076 Dispersing agents for use with hydrofluoroalkane propellants
03/26/1996US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents
03/26/1996US5502074 Benzothiophenes for bone healing and fracture repair
03/26/1996US5502072 Substituted oxindoles
03/26/1996US5502068 Cyclopropylpyrroloindole-oligopeptide anticancer agents
03/26/1996US5502067 Sleep disorders, pilocarpine
03/26/1996US5502066 Inhibitors of tumor necrosis factors
03/26/1996US5502065 Indole derivatives as 5-HT1 -like agonists
03/26/1996US5502064 Cns disorders
03/26/1996US5502063 1-halopyridin-4-amino-4-alkylpiperidines
03/26/1996US5502062 2-amino-4-quinolyl-dihydropyridines, processes for their preparation, and their use
03/26/1996US5502060 HIV protease inhibitors
03/26/1996US5502059 Substituted 1-naphthyl-3-pyrazolecarboxamides which are active on neurotensin, their preparation and pharmaceutical compositions containing them
03/26/1996US5502058 Lidocaine and dextromethorphan or dextrophan
03/26/1996US5502056 Stimulant, antisoporific, salt with p-aminobenzoic acid
03/26/1996US5502055 Treatment of endotoxic shock with putrescine
03/26/1996US5502052 Use of a combination of apraclonidine and timolol to control intraocular pressure
03/26/1996US5502051 Central nervous system, antispasmodic
03/26/1996US5502050 Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis
03/26/1996US5502049 Use of phenothiazine derivatives in the treatment of ischaemia and/or hypoxia
03/26/1996US5502048 Cns, strokes, hypoglycemic agents and antiischemic agents
03/26/1996US5502047 Treatment for insomnia
03/26/1996US5502046 11β-substituted 14,17-ethanoestratrienes, process for their production and their use as pharmaceutical agents
03/26/1996US5502045 Use of a stanol fatty acid ester for reducing serum cholesterol level
03/26/1996US5502044 Fluorinated 4-aminoandrostadienone derivatives and process for their preparation
03/26/1996US5502043 Use of hydroxyethyl starch for improvement of microcirculation
03/26/1996US5502041 Isolated from fucoidan
03/26/1996US5502040 Anticoccidial method
03/26/1996US5502038 Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption
03/26/1996US5502037 Antitumor agents for procytotoxic drugs
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501866 Product and method for inhibiting caffeine stimulation with theanine
03/26/1996US5501856 Controlled-release pharmaceutical preparation for intra-ocular implant
03/26/1996US5501855 Injection of neem oil into males
03/26/1996US5501850 Use of benzimidazole derivatives as light protection filters
03/26/1996CA1338190C 8,9-ANNELATED-ß-CARBOLINES AND 8,9-ANNELATED-3, 4-DIHYDRO-.BETA.-CAR BOLINES
03/26/1996CA1338189C 8,9-anellated-1,2,3,4-tetrahydro-.beta.-carboline derivatives
03/26/1996CA1338187C Halogen labeled compounds including estradiol derivatives, synthetic intermediates, syntheses thereof and uses thereof
03/26/1996CA1338185C Glycosidase inhibitor salbostatin, process for its preparation, and its use
03/26/1996CA1338184C Bu-3862t antitumor antibiotic
03/23/1996CA2132690A1 Control and modulation of inflammatory response in humans in need of such control and modulation
03/23/1996CA2132688A1 Anti-septic, spermicidal composition and means for its application
03/22/1996CA2158591A1 Fatty acid treatment
03/21/1996WO1996008527A1 Stacking-spiralized ortho-oligomer and a regulator of cell bioenergetic systems in eukaryotes and prokaryotes based on said oligomer
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues
03/21/1996WO1996008496A1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments
03/21/1996WO1996008495A1 Fused indole and quinoxaline derivatives, their preparation and use
03/21/1996WO1996008494A1 Indole-2,3-dione-3-oxime derivatives, their preparation and use
03/21/1996WO1996008493A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008492A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
03/21/1996WO1996008490A1 NOVEL MELATONIN AGONIST β-CARBOLINE DERIVATIVES AND ANALOGS WITH A NAPHTHALENIC STRUCTURE, METHOD FOR THEIR PREPARATION AND THEIR USE AS DRUGS
03/21/1996WO1996008489A1 Derivatives of benzopyran and of benzothiopyran, their preparation and their use as agonists of dopaminergic receptors
03/21/1996WO1996008485A1 Quinoxalinedione nmda receptor antagonists
03/21/1996WO1996008484A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/21/1996WO1996008480A1 Neurokinin antagonists
03/21/1996WO1996008478A1 Anti-hiv drug
03/21/1996WO1996008471A1 4-(4-methanesulfonamidophenyl)butylamine derivatives with antiarrhythmic activity
03/21/1996WO1996008463A1 Derivatives of 2-amino-1,2,3,4-tetrahydronaphthalene active on the cardiovascular system
03/21/1996WO1996008460A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same
03/21/1996WO1996008271A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996WO1996008270A2 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996WO1996008259A1 Synergistic antimicrobial composition
03/21/1996WO1996008258A1 Antimicrobial composition
03/21/1996WO1996008257A1 Synthetic ganglioside derivatives
03/21/1996WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
03/21/1996WO1996008254A1 Use of butaprost in pre-term labour
03/21/1996WO1996008253A1 Hydrocodone compositions
03/21/1996WO1996008252A1 Codeine containing formulations
03/21/1996WO1996008251A1 Scopolamine plaster
03/21/1996WO1996008250A1 Fibrinogen receptor antagonists
03/21/1996WO1996008249A1 Inhibition of hemoflagellates by camptothecin compounds
03/21/1996WO1996008248A1 Compositions for the treatment of skin disorders
03/21/1996WO1996008247A1 Anti-helicobacter agent
03/21/1996WO1996008246A2 Inducers of gamma globin gene expression and screening assays therefor
03/21/1996WO1996008245A1 Patch for external use
03/21/1996WO1996008243A1 Pharmaceutical preparation containing metformin and a process for producing it
03/21/1996WO1996008242A2 Clotrimazole metabolites in the treatment of sickle cell disease
03/21/1996WO1996008241A1 Anaesthetic analgesic gas mixtures containing enflurane or isoflurane in combination with sevoflurane or desflurane
03/21/1996WO1996008240A1 Use of aromatic halides for treating mammalian cell proliferation
03/21/1996WO1996008239A1 Use of 5-alpha-reductase inhibitors to increase hdl cholesterol levels
03/21/1996WO1996008238A1 Use of paracellular absorption enhancers such as glucose for enhaincing the absorption of histamine h2-antagonists
03/21/1996WO1996008231A1 Control of hair growth
03/21/1996WO1996008228A2 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/21/1996DE4438989A1 Scopolaminpflaster Scopolaminpflaster
03/21/1996DE4432947A1 Skin-treating agent contg. isoflavone or deriv.
03/21/1996DE4432757A1 Pharmazeutische Zubereitung enthaltend Metformin und Verfahren zu deren Herstellung Pharmaceutical composition comprising metformin and methods of their production
03/21/1996DE4432633A1 Pharmaceutical prepn. for local treatment of chronic skin inflammation
03/21/1996DE19534744A1 Neues pharmazeutisches Produkt New pharmaceutical product
03/21/1996CA2200085A1 Control of hair growth
03/21/1996CA2200083A1 Neurokinin antagonists
03/21/1996CA2200056A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2200055A1 [1,2,4]triazolo[4,3-a]quinoxalinone derivatives, their preparation and use
03/21/1996CA2199944A1 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
03/21/1996CA2199730A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996CA2199484A1 Derivatives of 2-amino-1,2,3,4-tetrahydro-naphthalene active on the cardiovascular system
03/21/1996CA2199416A1 Inducers of gamma globin gene expression and screening assays therefor
1 ... 6932 6933 6934 6935 6936 6937 6938 6939 6940 6941 6942 6943 6944 6945 6946 6947 6948 6949 6950 6951 6952 ... 7860